Font Size:
a
A
A
Keyword [immune checkpoint]
Result: 41 - 60 | Page: 3 of 10
41.
Preparation Of Mouse Anti-human PD-1 Monoclonal Antibody And Identification Of Its Biological Characteristic
42.
The Research Progress On PD-1/PD-L1 Immune Checkpoint Inhibitor Treating Advanced Bladder Cancer
43.
Clinical Significance And Mechanism Of PD-L1 Expression In Glioma
44.
Progress Of Immunotherapy For Gastric Cancer
45.
Toxicities And Management Of Immune Checkpoint Inhibitors In Cancer Immunotherapy
46.
Study On The Role And Mechanism Of Local Renin-angiotensin System In Immune-checkpoint Blockade Resistance
47.
Study On The Mechanism Of PD-1 McAb Combined With Cytokine IL-33 In Antitumor Immune Response
48.
Biological Function Study Of Anti-human TIM-3 Monoclonal Antibody In Vitro
49.
Relationship Between PD-L1 Expression And EGFR,ALK In Non-small Cell Lung Cancer And Its Clinical Significance
50.
Reactive Oxygen Species Responsive Micelles Based Two-photon Photodynamic Therapy In Combination With Immune Checkpoint Therapy Against Breast Cancer
51.
Post-marketing Study Of Safety Of Immune Checkpoint Inhibitor Based On Spontaneous Reporting System
52.
The Combination Of Tumor Lysate Loaded Nanovaccine And ~DPPA-1 To Induce Antitumor Immunity And Block Immune Checkpoint For Cancer Immunotherapy
53.
New Progress Of Immune Checkpoint Inhibitors In The Treatment Of Lung Cancer
54.
The Efficacy And Safety Of PD-1/PD-L1 Inhibitors Versus Chemotherapy In The Treatment Of Non Small Cell Lung Cancer-a Meta Analysis
55.
Expression Of PD-1 And TIM-3 Immune Checkpoint Receptors On Tissues And Peripheral Blood Of T Cell Of Patients With Oral Squamous Cell Carcinoma
56.
Expression And Clinical Significance Of B7 Family Member HHLA2 In Hepatocellular Carcinoma
57.
The Incidence And Risk Factors Of Pneumonitis In Patients Treated With Immune Checkpoint Inhibitors
58.
A Preliminary Study On The Role And Mechanism Of Macrophage-associated Immune Checkpoint Molecular Imbalance In Heterotopic Ossification
59.
Expression And Its Clinical Significance Of Immuno-costimulatory Molecule B7-H3 In Blood And Cerebrospinal Fluid Of Patients With Glioma
60.
Efficacy And Immune-related Adverse Events Induced By PD-1/PD-L1 And CTLA-4 Inhibitors In Advanced NSCLC
<<First
<Prev
Next>
Last>>
Jump to